Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028774 |
---|---|
Receipt number | R000032851 |
Scientific Title | Meta-analysis of Abraxane used as a neo-adjuvant chemotherapy for operable breast cancer |
Date of disclosure of the study information | 2017/09/01 |
Last modified on | 2021/07/02 10:08:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/08/22 14:22:43 | ||
2 | Update | 2017/09/15 20:56:13 | Date of protocol fixation Anticipated trial start date |
|
3 | Update | 2018/01/30 18:46:30 | Recruitment status |
|
4 | Update | 2018/08/23 17:47:58 | Public title |
|
5 | Update | 2018/08/24 10:11:14 | UMIN ID1 |
|
6 | Update | 2019/08/26 14:45:39 | Recruitment status Date of IRB Last follow-up date |
|
7 | Update | 2019/09/05 16:31:22 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
8 | Update | 2019/09/05 16:34:04 | Number of participants that the trial has enrolled |
|
9 | Update | 2021/07/01 14:42:21 | Recruitment status |
|
10 | Update | 2021/07/01 14:48:02 | Last name of contact person Last name of contact person Division name Homepage URL Name of person sending information Name of person sending information Division name Address |
|
11 | Update | 2021/07/02 10:08:44 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |